419POutcomes of gemcitabine-docetaxel as second-line chemotherapy in patients of advanced soft tissue sarcoma: A retrospective analysis. (25th November 2018) - Gupta, K; Parthiban, S; Kumar, S; Srinivas, S; Vallathol, D H; Chanana, R; Grewal, G S; Rathnasamy, N; Goel, A; Bajpai, J